Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model
- 28 June 2011
- Vol. 29 (35), 6008-6016
- https://doi.org/10.1016/j.vaccine.2011.06.034
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Suspected Yellow Fever Vaccine-Associated Viscerotropic Adverse Events (1973 and 1978), United StatesThe American Journal of Tropical Medicine and Hygiene, 2010
- Efficacy of 2′-C-methylcytidine against yellow fever virus in cell culture and in a hamster modelAntiviral Research, 2010
- Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106Antimicrobial Agents and Chemotherapy, 2009
- Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In VivoJournal of Virology, 2008
- Epitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized AntibodyJournal of Virology, 2007
- Defining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster ModelAntimicrobial Agents and Chemotherapy, 2007
- Activity of T-1106 in a Hamster Model of Yellow Fever Virus InfectionAntimicrobial Agents and Chemotherapy, 2007
- Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster modelAntiviral Research, 2006
- Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccineVaccine, 2006
- Antibody Prophylaxis and Therapy against West NileVirus Infection in Wild-Type and ImmunodeficientMiceJournal of Virology, 2003